InvestorsHub Logo

srinsocal

01/05/18 8:53 AM

#119116 RE: cashpot #119107

Thanks for your efforts cashpot, This is Fantastic news for BIEL and needs to be Shouted from the Rooftops for everyone to hear!

I love this quote from our VP of Sales,

"We commend this move by the NHS, as this will open up the doors for reimbursement in the US and other managed care markets. This will likely have a tremendous impact on our sales and marketability of the product in the UK and elsewhere".

And this one from the mHealth Intelligence article showing how BIEL's efforts in 2017 are now paying off,

"BioElectronics officials say NHS approval was linked to a study in which treatment with the mHealth wearable helped reducers reduce their trips to the doctor’s office by almost 60 percent and cut prescription drug costs by 35 percent, resulting in an overall reduction in healthcare costs of 45 percent."


With all major healthcare providers struggling to do more for their customers while containing expenses how could any of them not consider the savings of providing ActiPatch for pain management.

https://mhealthintelligence.com/news/uk-approves-wearable-mhealth-device-for-chronic-pain-management

http://www.nasdaq.com/press-release/bioelectronics-actipatch-drug-free-pain-therapy-receives-united-kingdom-national-health-system-20180104-00229